theories, and accept that they do not know everything. At the same time, the field also teaches immense persistence, as meaningful breakthroughs rarely happen overnight. Watching passionate professionals persist through these difficulties and succeed together also serves as a crucial driver for Katleen. “I am equally inspired by teams who overcome significant challenges together,” she told us. “Some of the proudest moments in my career were not individual achievements, but watching teams accomplish things that many believed were impossible. The world’sfirst progress we achieved recently in ultrasensitive PCR testing was not the result of a single insight; it was the outcome of extraordinary teamwork, perseverance, and collective belief in a difficult mission.” The past few years have reinforced the importance of unwavering resilience for Katleen and her team. Like many organisations, miDiagnostics has faced moments of considerable uncertainty, including the process of reinventing its business model, securing alignment among stakeholders, and continuing to innovate under increasing pressure. Demonstrating inimitable innovation, teamwork, and a willingness to challenge conventional thinking, the team successfully reinvented miDiagnostics to the point of delivering a world-first achievement to the sector. Speaking of her team’s unprecedented breakthrough, Katleen commented, “Our progress has reinforced my belief that extraordinary things happen when exceptional people unite around a challenging problem with a clear purpose.” As miDiagnostics repivoted to align with the shifting market, Katleen found herself evolving alongside her team. She developed her appreciation for patience, communication, and trust; earlier in her career, Katleen often felt responsible for solving every challenge personally but now recognises that the best solutions often emerge when teams are empowered to contribute their expertise. Today, she sees leadership less as directing and more as enabling, with her role being to create clarity, remove obstacles, inspire confidence during uncertainty, and help people achieve more than they thought possible. Having shifted her leadership style through the years, Katleen now has more capacity expand her influence beyond miDiagnostics. Energised by the prospect of pursuing opportunities where science, innovation, and entrepreneurship come together to solve meaningful problems, Katleen is increasingly passionate about supporting and mentoring the next generation to lead the life sciences sector. One such example is the CEO’s ongoing involvement with 4Tissue, a company pioneering the field of regenerative medicine by developing natural and minimally invasive treatments for tissue reconstruction and regeneration. As the Chair of the Board of Directors of 4Tissue, Katleen has had the privilege of supporting an ambitious young CEO as the company advances regenerative medicine solutions. She told us, “Watching emerging leaders build strong teams, attract investment, and accelerate innovation is incredibly rewarding.” The CEO’s hard work has certainly been recognised; in November 2025, Katleen was honoured with the Exemplary Woman of Achievement Award in the 8th Burj CEO Awards 2025 in Dubai. This recognition did not only celebrate Katleen’s individual leadership, but also the vision, dedication, and collaboration of her team. This moment was made extra special for Katleen, as she had the opportunity to share it with her 14 year old son, Bodhi. Together, they walked the red carpet and participated in the award ceremony, creating a shared memory that neither will ever forget. “For me, that moment symbolised something much bigger than professional success,” said Katleen. “It reinforced the importance of leading by example, demonstrating perseverance, and inspiring future generations to believe that they too can make a meaningful contribution to society through dedication, integrity, and hard work. My motto at the award ceremony was: ‘dream big, take risks, dare to fall, one bold step at a time’.” This motto perfectly encapsulates all that Katleen and her team have achieved at miDiagnostics. Now that the team has proven the successful reinvention of miDiagnostics with the delivery of its ground-breaking ultra-sensitive PCR sterility solution, the focus remains on bringing innovative sterility testing solutions to market and supporting the growing advanced therapy ecosystem. The team is working alongside leading pharmaceutical organisations that recognise the transformative potential of faster and more reliable quality control testing. “At the same time, we continue to strengthen our ecosystem of partners, collaborators, and industry leaders,” Katleen added. “Some of the most important innovations happen at the intersection of disciplines, and we intend to remain at the forefront of those collaborations. Most importantly, we remain focused on turning scientific excellence into practical solutions that make a tangible difference for patients worldwide.” We at EU Business News Magazine are delighted to have witnessed miDiagnostics’ pivot from reinvention to reshaping the industry and believe that the company’s journey is a testament to the strength of its team, the power of its innovation, and the unwavering determination of its CEO. For demonstrating the importance of empowerment, trust, and ongoing evolution in leadership, Katleen has been deservingly named Best Health Screening Solutions CEO, for the third consecutive year, as miDiagnostics is celebrated as Most Innovative Molecular Diagnostics Company 2026. Off the back of this monumental success, Katleen shared her closing thoughts: “Leadership is ultimately about people. While awards are individual recognitions, every achievement I have been fortunate enough to receive reflects the efforts of the exceptional teams, mentors, partners, investors, and family members who have supported the journey.”
RkJQdWJsaXNoZXIy MTUyMDQwMA==